about
Polymorph Impact on the Bioavailability and Stability of Poorly Soluble DrugsPolymeric micelles for multi-drug delivery in cancerEffect of formulation variables on preparation of celecoxib loaded polylactide-co-glycolide nanoparticlesIdentification of New Molecular Entities (NMEs) as Potential Leads against Tuberculosis from Open Source Compound RepositoryInhibitory Activity of (+)-Usnic Acid against Non-Small Cell Lung Cancer Cell MotilityA Toxicological Framework for the Prioritization of Children's Safe Product Act DataModern evaluation of liquisolid systems with varying amounts of liquid phase prepared using two different methods.Photoclick Hydrogels Prepared from Functionalized Cyclodextrin and Poly(ethylene glycol) for Drug Delivery and in Situ Cell Encapsulation.Identification of small molecule inhibitors of the Aurora-A/TPX2 complexNanocarrier for poorly water-soluble anticancer drugs--barriers of translation and solutions.Formulation and evaluation of biodegradable nanoparticles for the oral delivery of fenretinide.A menthol-based solid dispersion technique for enhanced solubility and dissolution of sulfamethoxazole from an oral tablet matrix.Development and evaluation of N-naphthyl-N,O-succinyl chitosan micelles containing clotrimazole for oral candidiasis treatment.Synthesis and in vitro evaluation of water-soluble 1,4-diphenethylpiperazine analogs as novel inhibitors of the vesicular monoamine transporter-2Hydrophilically modified self-assembling α-tocopherol derivative as niosomal nanocarrier for improving clarithromycin oral bioavailability.Conjugation of Hot-Melt Extrusion with High-Pressure Homogenization: a Novel Method of Continuously Preparing Nanocrystal Solid Dispersions.Acyclic Cucurbit[n]uril-Type Molecular Container Enables Systemic Delivery of Effective Doses of Albendazole for Treatment of SK-OV-3 Xenograft TumorsNanostructured lipid carriers: versatile oral delivery vehicle.2-Hydroxy-3-methoxybenzoic acid attenuates mast cell-mediated allergic reaction in mice via modulation of the FcεRI signaling pathway.Lifitegrast: A novel drug for treatment of dry eye disease.Recent progress in tight junction modulation for improving bioavailability.Abuse-deterrent formulations: part 1 - development of a formulation-based classification system.Drug nanosuspensions: a ZIP tool between traditional and innovative pharmaceutical formulations.Niclosamide piperazine prevents high-fat diet-induced obesity and diabetic symptoms in mice.Supercritical Fluid Technology: An Emphasis on Drug Delivery and Related Biomedical Applications.Liquigroud technique: a new concept for enhancing dissolution rate of glibenclamide by combination of liquisolid and co-grinding technologies.In vitro oral drug permeation models: the importance of taking physiological and physico-chemical factors into consideration.Physiologically-based pharmacokinetic models: approaches for enabling personalized medicine.Synthesis and biological evaluation of novel 3-alkylpyridine marine alkaloid analogs with promising anticancer activity.Novel Nanoprinting for Oral Delivery of Poorly Soluble Drugs.Isoprenyl carboxyl methyltransferase inhibitors: a brief review including recent patents.Influence of the microwave technology on solid dispersions of mefenamic acid and flufenamic acid.Discovery of anthranilamides as a novel class of inhibitors of neurotropic alphavirus replication.Nutraceutical Value of Pure CurcuminFormulation Development of Spherical Crystal Agglomerates of Itraconazole for Preparation of Directly Compressible Tablets with Enhanced Bioavailability.Preformulation and Vaginal Film Formulation Development of Microbicide Drug Candidate CSIC for HIV prevention.D-optimal Design for Preparation and Optimization of Fast Dissolving Bosentan Nanosuspension.Preparation and Optimization OF Palm-Based Lipid Nanoparticles Loaded with GriseofulvinSwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules.Printing of small molecular medicines from the vapor phase.
P2860
Q26779030-3224A3D2-23AA-474E-9A55-8F4D4A832804Q27025861-4040B892-A77A-4F28-82A0-E140A49162ABQ28542696-5E9705AB-8C2F-49C7-AE4B-8ED6499FD854Q28551394-4980860B-835F-4F04-A67E-6131C7BED28AQ28552254-68ED8DA3-CA10-4940-96A3-EE43829FA690Q28834101-1AAB7851-63CF-4E48-81D0-FC7EF5EF0FBDQ30409303-3C353DC9-0458-49D4-8407-4586B9BD6C84Q33744561-11CEF898-D7B8-4D58-A1FF-D4BE9335A3FAQ33762037-FC753447-87B3-4A59-A86B-D7E26249221DQ33962553-C6819B70-041A-4A2A-B880-197DBA2A468BQ35706314-F541D55D-D626-48A1-8FD0-45E9D2ABDDE8Q35868332-6FC3A61A-BF23-4FFB-8659-5F97CF1BFADCQ35981210-CCAE3E2F-BCB4-453D-936C-CCD02159601FQ36103932-D5B7255A-6A3A-4CDF-A393-5DE8700298D7Q36379940-1FD13E7B-8FE9-4BD9-9DCE-3902FF013B20Q36614773-A9F8CA67-8030-43FA-A1B8-96DAF22A4023Q36665183-29D7450C-7405-4B26-B93F-E1E1253E923CQ37474497-F8CF9C6A-775D-40E7-8665-348D9D28141EQ37571914-62024D1C-6D7E-4339-878D-27B2E5633B42Q37591609-ED6E6AE5-5CC5-4F05-9342-CA9782B29155Q38190079-D2939D1C-467F-4F05-9B3F-B4FA9EEEEC92Q38265486-C875ADFD-A291-4CE3-8342-57F2356819BFQ38470559-65BB880D-037D-44C0-8EF2-98EFE781BA82Q38646388-B8237357-A88D-4220-A6C1-2B09118A13F7Q38655920-992E5B89-9D26-4272-928A-3373A6B72FFBQ38762614-7217C796-3743-4A9B-A27F-8AEB7AB964E1Q38891721-C03940C0-AB53-4D40-873D-E61AFA530048Q38959281-655DCBC9-E4E1-4E72-9C85-8AA5769BC1CCQ38968938-CD2EAC0D-2313-4BCB-89AC-3FF52EF593B7Q39003373-42554941-E120-4992-BD87-2D0B1E2BBDD1Q39384869-C6FF7C28-46C1-4B84-8537-34417F9563DEQ41186149-3785EE31-D7FF-4490-8839-7894DEBFBE5FQ41449946-3B4C403E-2A8A-4283-A1D6-148E81D56E6CQ41941531-B585B544-71EE-49A1-A092-A73863790FD5Q41987485-46F0A8AB-9C13-4FF7-B583-C012557A1572Q41990616-B32B8E09-0218-4564-BC0B-4FE1356F0F32Q42012709-318405EB-13D6-4D0A-AAA2-A67D31ED7F48Q42116307-97BB071D-368A-4114-855D-3213186CB2E9Q42318665-0FEC7476-EBD3-4A09-844D-7B2E6FDF975DQ42365551-FC127D00-F190-4FE6-9571-39D6F8D02F0D
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Drug solubility: importance and enhancement techniques.
@en
type
label
Drug solubility: importance and enhancement techniques.
@en
prefLabel
Drug solubility: importance and enhancement techniques.
@en
P2093
P2860
P356
P1433
P1476
Drug solubility: importance and enhancement techniques.
@en
P2093
Anuradha K Gajjar
Jignasa K Savjani
Ketan T Savjani
P2860
P304
P356
10.5402/2012/195727
P577
2012-07-05T00:00:00Z